Sana Biotechnology, Inc.

US$2.37As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:SANAHealthcare
Country USA
PE (Fwd) •••
TSR 6Y CAGR (36.25%)
Div yield —
ROE (79.47%)
Biotechnology
Beta (5Y) 2.30
PE TTM —
TSR TTM (52.12%)
Mkt cap US$710.1M
ROIC (34.18%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$2.61
10.04%
102.32%
Buy 8|2|3|0|0
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.03
0.03
0.03
0.03
2.39%
4.84%
7.97%
13.38%
Revenue$M
79.39
84.05
82.03
84.37
3.72%
6.63%
4.29%
4.71%
Peers (US$710.1M)
Cap (US$)
PE
723.1M
4.629x
Capital
TTM
5Y
10Y
Leveragex
0.622
1.117
0.948
EBIT/Intx
1.272
0.123
0.147
Own earn%
(1.63)
47.76
45.20
Sh yield%
53.51
15.43
18.84
Owners
Insiders/Inst%
1.60
86.78
Short interest%
4.44
SBC / revenue%
3.10
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
2
Op margin range%
0–13
$1 testx
—
Incr. ROIC%
0